Addiction and the Brain: Treatments, Patterns, and Recovery at The Francis Crick Institute

In this Question of Science episode, a panel of addiction experts from the Francis Crick Institute and King's College London explores how addiction works in the brain, across substances and behaviours, and what science offers for treatment and recovery. A recovering addict on the panel shares his lived experience to illuminate relapse, recovery, and the role of support. The discussion covers patterns such as progression from drugs to alcohol to nicotine, the impact of environment and stigma, the complexity of smartphone and social media use as potential behavioural addictions, and the promise of psychedelic therapies like psilocybin. The panel also addresses the societal changes needed to improve access to care and reduce harm.

• Brain circuits and cues drive addictive seeking and withdrawal
• Recovery is a nonlinear process with relapse common but manageable
• Psychedelics and ADHD medication are being explored as treatments

Overview

The podcast gathers a multidisciplinary panel from The Francis Crick Institute and King's College London to tackle addiction in its many forms, from substances such as alcohol and cocaine to behaviours like smartphone use and gambling. Through personal testimony and expert analysis, the discussion navigates how addictions are defined, how they manifest in the brain, and how treatments are evolving. The episode also considers the social and policy context that shapes access to care and recovery prospects.

Panel and Context

The participants include Sally Marlow, a professor of public understanding of mental health research; Matt Willis, a recovering addict who hosts a podcast about addiction; Nicky Kolk, an addiction psychiatrist; and David Nutt, a neuropsychopharmacology professor. The conversation opens with Matt sharing his long journey through rehab and his realization that addiction can begin in childhood, with patterns that persist across substances and time. The panel emphasizes that there is no single addiction type and that patterns often involve transitions between substances and behaviours rather than a fixed disease of one drug.

What is Addiction?

The experts discuss a clinical view of addiction as repetitive, often destructive behavior that is hard to stop, with withdrawal playing a central role in why users continue. They acknowledge that addiction can be framed as a disease with brain structure and function changes during the shift from impulsive to compulsive use, yet caution that framing can influence prognosis and identity. The distinction between casual use and clinically significant addiction is tied to health harms, persistence, and the need for help.

Biopsychosocial Underpinnings

The conversation highlights a mix of genetic predisposition and environmental factors, including childhood adversity, family behaviour, and broader social circumstances. The brain’s reward circuits, cue-triggered motivation, and the interplay of impulsivity and habit formation are explained in accessible terms. The panel notes that even non-substance addictions, such as caffeine, illustrate tolerance and withdrawal phenomena, underscoring the continuum between everyday use and problematic behaviour.

Patterns of Addiction and Transition

Audience questions address patterns across substances and the notion that many people progress through different addictions over time. The panel discusses how nicotine often remains as a persistence after ceasing other substances and how caffeine can represent a non-harmful form of addiction in some contexts. They also discuss how the environment and social context shape progression and relapse risk, including reduced access to community resources and enrichment in adolescence.

Behavioural Addictions and the Brain

A participant asks whether behaviours like social media use share common neurobiological substrates with substance addictions. The experts describe evidence from reward pathways showing endorphin and dopamine-like responses that can be engaged by gambling and alcohol, with the possibility of similar mechanisms in phone and social media use. The ABCD study findings are cited to connect pattern, age, and mental health harms such as suicidality with problematic screen use.

ADHD, Neurodiversity and Addiction

The panel discusses ADHD as a risk factor for substance use disorders and behavioural addictions, linking this to dopamine system differences and impulsivity. They highlight that treatment with ADHD medications can reduce risk factors and improve engagement with addiction treatment, especially when started early. The conversation also draws attention to stigma around ADHD and the need to keep at-risk youth in supportive educational environments.

Recovery, Meaning, and Society

The discussion returns to social factors and the necessity of meaningful activity, purpose, and social connection in recovery. Matt describes how music gave him purpose, illustrating how structured, fulfilling activities can anchor sobriety. The speakers stress that recovery is a journey and relapse does not equal failure. They also critique policy decisions that pathologize addiction without addressing social determinants such as housing, employment, and community access to care.

Psychedelics as Therapeutics

The panel considers psychedelics, specifically psilocybin and LSD, as potential tools for resetting neural networks involved in addictive behaviours. They discuss safety considerations and the importance of controlled, therapeutic environments. There is emphasis on the trip experience as a meaningful factor in changing self-perception and motivation for change. The possibility of non-hallucinogenic psychedelic-like treatments is acknowledged, but the current evidence suggests the experiential component plays a role in efficacy.

Audience Perspectives and Support Networks

Audience questions address stigma, anonymity in recovery programs, and the responsibility of friends and families. The panel underscores the value of mutual aid groups and the need to reduce barriers to entering treatment. They discuss strategies for supporting loved ones, including education for families about enabling behaviours and boundaries while acknowledging the disease-like nature of addiction.

Conclusions

The episode closes with reflections on the need for societal-level changes to improve treatment access, reduce stigma, and invest in prevention and recovery infrastructure. The scientists reiterate that while cures are not guaranteed, advances in neuroscience, pharmacology, and psychosocial supports offer real avenues for reducing harms and improving recovery outcomes.

Overall, the podcast presents a nuanced, evidence-informed view of addiction as a complex, brain-based condition embedded in social and environmental contexts, with multiple pathways to recovery and an urgent need for comprehensive support systems.